AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19675681 — intervention group
Group type: EXPERIMENTAL
Intervention: History and Physical Examination (H&P) estimates of RAP
Number of subjects: 388
Study 19675681 — intervention group
Group type: EXPERIMENTAL
Intervention: History and Physical Examination (H&P) estimates of orthopnea
Number of subjects: 388
Study 19675681 — intervention group
Group type: EXPERIMENTAL
Intervention: Discharge 'cold' or 'wet' profile
Number of subjects: 388
Study 19675681 — intervention group
Group type: EXPERIMENTAL
Intervention: Measured cardiac index
Number of subjects: 388
Study 19675681 — intervention group
Group type: EXPERIMENTAL
Intervention: H&P estimates of cardiac index
Number of subjects: 388
Study 15533351 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH analogue plus add-back therapy
Number of subjects: 133
Study 15533351 — intervention group
Group type: COMPARATOR
Intervention: GnRH analogue alone
Number of subjects: 133
Study 15533351 — intervention group
Group type: COMPARATOR
Intervention: Estroprogestin
Number of subjects: 133
Study 11878688 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil (group R, n=30)
Number of subjects: 60
Study 11878688 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane (group S, n=30)
Number of subjects: 60
Study 9559374 — intervention group
Group type: EXPERIMENTAL
Intervention: Smokers
Number of subjects: 25
Study 9559374 — intervention group
Group type: COMPARATOR
Intervention: Nonsmokers
Number of subjects: 25
Study 7878376 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral counselling individualized according to functional analysis
Number of subjects: 20
Study 7878376 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 20
Study 3277588 — intervention group
Group type: EXPERIMENTAL
Intervention: One day of cefonicid sodium therapy
Number of subjects: 248
Study 3277588 — intervention group
Group type: COMPARATOR
Intervention: Five days of cefonicid sodium therapy
Number of subjects: 248
Study 3277588 — intervention group
Group type: COMPARATOR
Intervention: Five days of cefamandole nafate therapy
Number of subjects: 248
Study 29455298 — intervention group
Group type: EXPERIMENTAL
Intervention: Anastrozole (1 mg/day)
Number of subjects: 686
Study 29455298 — intervention group
Group type: COMPARATOR
Intervention: Exemestane (25 mg/day)
Number of subjects: 686
Study 29455298 — intervention group
Group type: EXPERIMENTAL
Intervention: Anastrozole (1 mg/day) and Exemestane (25 mg/day)
Number of subjects: 686
Study 25331064 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylene blue injection into the superior rectal artery
Number of subjects: 131
Study 25331064 — intervention group
Group type: COMPARATOR
Intervention: Control group (palpation and sight)
Number of subjects: 131
Study 25331064 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylene blue injection
Number of subjects: 131
Study 25442722 — intervention group
Group type: EXPERIMENTAL
Intervention: Buffered 2% lidocaine with 1:80,000 epinephrine buffered with 0.18 mL 8.4% sodium bicarbonate
Number of subjects: 80
Study 25442722 — intervention group
Group type: COMPARATOR
Intervention: Nonbuffered 2% lidocaine with 1:80,000 epinephrine with 0.18 mL sterile distilled water
Number of subjects: 80
Study 23678970 — intervention group
Group type: EXPERIMENTAL
Intervention: Surface Perturbation Treadmill Training (SPTT)
Number of subjects: 73
Study 23678970 — intervention group
Group type: COMPARATOR
Intervention: Standard Physical Therapy (Standard PT)
Number of subjects: 73
Study 21395453 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 343
Study 21395453 — intervention group
Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 343
Study 18446549 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture and/or interocclusal appliance therapy
Number of subjects: 65
Study 17278415 — intervention group
Group type: EXPERIMENTAL
Intervention: Exoneration from blame (exonerated group)
Number of subjects: 48
Study 17278415 — intervention group
Group type: COMPARATOR
Intervention: Nonaddressed group (no exoneration)
Number of subjects: 48
Study 17278415 — intervention group
Group type: COMPARATOR
Intervention: Neutral discussion group
Number of subjects: 48
Study 14685445 — intervention group
Group type: EXPERIMENTAL
Intervention: Etoposide in the induction phase
Number of subjects: 83
Study 14685445 — intervention group
Group type: EXPERIMENTAL
Intervention: German protocol (after 1991)
Number of subjects: 83
Study 14685445 — intervention group
Group type: COMPARATOR
Intervention: No intervention (before 1991)
Number of subjects: 83
Study 14685445 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival
Number of subjects: 83
Study 14685445 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous complete remission
Number of subjects: 83
Study 11061985 — intervention group
Group type: EXPERIMENTAL
Intervention: Zafirlukast (40 mg oral)
Number of subjects: 16
Study 11061985 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 9490579 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% hydroxyethyl starch (HES)
Number of subjects: 7
Study 9490579 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% gelatin (GEL)
Number of subjects: 7
Study 9490579 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 7
Study 1539519 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 39
Study 1539519 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 39
Study 1539519 — intervention group
Group type: EXPERIMENTAL
Intervention: Ouabain
Number of subjects: 39
Study 1539519 — intervention group
Group type: EXPERIMENTAL
Intervention: Cedilanid
Number of subjects: 39
Study 1539519 — intervention group
Group type: EXPERIMENTAL
Intervention: Procainamide
Number of subjects: 39
Study 1539519 — intervention group
Group type: COMPARATOR
Intervention: Control group (7 patients)
Number of subjects: 39
Study 3927690 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 17
Study 3927690 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin after aspirin treatment
Number of subjects: 17
Study 31568696 — intervention group
Group type: EXPERIMENTAL
Intervention: Serelaxin treatment
Number of subjects: 1120
Study 31568696 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1120
Study 31568696 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated MELD‐XI score on admission
Number of subjects: 1120
Study 31568696 — intervention group
Group type: EXPERIMENTAL
Intervention: MELD‐XI score addition to prognostic model
Number of subjects: 1120
Study 30345884 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaparib (300 mg twice daily)
Number of subjects: 391
Study 30345884 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 391
Study 27003517 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal ranibizumab injection (IRI)
Number of subjects: 38
Study 24461901 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol
Number of subjects: 7376
Study 24461901 — intervention group
Group type: COMPARATOR
Intervention: Tiotropium
Number of subjects: 7376
Study 23246790 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based intervention
Number of subjects: 0
Study 23246790 — intervention group
Group type: COMPARATOR
Intervention: Printed intervention
Number of subjects: 0
Study 21526670 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal sufentanil 0.05/kg
Number of subjects: 60
Study 21526670 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 60
Study 21526670 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal sufentanil
Number of subjects: 60
Study 17272671 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower body negative pressure (LBNP) at 35 mmHg
Number of subjects: 16
Study 17272671 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower body negative pressure (LBNP) at 15 mmHg
Number of subjects: 16
Study 17272671 — intervention group
Group type: EXPERIMENTAL
Intervention: BOLD signal changes during LBNP
Number of subjects: 16
Study 15345982 — intervention group
Group type: EXPERIMENTAL
Intervention: Vented reamed intramedullary nailing
Number of subjects: 12
Study 15345982 — intervention group
Group type: COMPARATOR
Intervention: Nonvented reamed intramedullary nailing
Number of subjects: 12
Study 11594442 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeinated drink (100 mg caffeine) consumed by the test group when undeprived on days 1-4, tested when caffeine-deprived on day 5.
Number of subjects: 52
Study 11594442 — intervention group
Group type: COMPARATOR
Intervention: Caffeinated drink consumed by the deprived control group.
Number of subjects: 52
Study 11594442 — intervention group
Group type: COMPARATOR
Intervention: Placebo drink consumed by the deprived control group.
Number of subjects: 52
Study 9767255 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical melatonin with vitamins E and C
Number of subjects: 0
Study 9767255 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical vitamin C alone
Number of subjects: 0
Study 9767255 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical vitamin E alone
Number of subjects: 0
Study 9767255 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical melatonin alone
Number of subjects: 0
Study 9767255 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical combination of vitamins E and C
Number of subjects: 0
Study 8093132 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide-5-mononitrate (20 mg twice daily)
Number of subjects: 116
Study 8093132 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study 2542193 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional radiotherapy (6000 cGy in 30-35 fractions) + BCNU
Number of subjects: 603
Study 2542193 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional radiotherapy + streptozotocin
Number of subjects: 603
Study 2542193 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperfractionated (twice daily) radiotherapy (6600 cGy in 60 fractions) + BCNU
Number of subjects: 603
Study 2542193 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional radiotherapy with misonidazole followed by BCNU
Number of subjects: 603
Study 30307966 — intervention group
Group type: EXPERIMENTAL
Intervention: Functionally orientated treatment based on the shortened dental arch (SDA) concept
Number of subjects: 89
Study 30307966 — intervention group
Group type: COMPARATOR
Intervention: Removable partial dentures (RPDs)
Number of subjects: 89
Study 28101560 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary assessment and individualized rehabilitation interventions
Number of subjects: 308
Study 28101560 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 308
Study 26404420 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-based intervention (N=70)
Number of subjects: 136
Study 26404420 — intervention group
Group type: COMPARATOR
Intervention: Information-monitoring control condition (N=66)
Number of subjects: 136
Study 24548447 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized chemotherapies based on ERCC1 and TOPO I expression results
Number of subjects: 90
Study 24548447 — intervention group
Group type: COMPARATOR
Intervention: Random chemotherapies
Number of subjects: 90
Study 24548447 — intervention group
Group type: EXPERIMENTAL
Intervention: Estimated drug tolerated group (ERCC1 high expression or TOPO I low expression)
Number of subjects: 90
Study 24548447 — intervention group
Group type: COMPARATOR
Intervention: Estimated drug sensitive group
Number of subjects: 90
Study 20577103 — intervention group
Group type: EXPERIMENTAL
Intervention: Early posttrabeculectomy IOP spike ≥5 mm Hg above baseline IOP
Number of subjects: 300
Study 20577103 — intervention group
Group type: COMPARATOR
Intervention: No IOP spike
Number of subjects: 300
Study 18440181 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal medical care (claudication pharmacotherapy)
Number of subjects: 252
Study 18440181 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary stent placement
Number of subjects: 252
Study 18440181 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise rehabilitation
Number of subjects: 252
Study 18440181 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined stenting with supervised exercise rehabilitation
Number of subjects: 252
Study 18440181 — intervention group
Group type: COMPARATOR
Intervention: All treatment strategies
Number of subjects: 252
Study 16778617 — intervention group
Group type: EXPERIMENTAL
Intervention: Inclusion of papillary muscles in LV mass calculations
Number of subjects: 100
Study 16778617 — intervention group
Group type: COMPARATOR
Intervention: Exclusion of papillary muscles in LV mass calculations
Number of subjects: 100
Study 12670841 — intervention group
Group type: EXPERIMENTAL
Intervention: On-deflate method without air in the stomach
Number of subjects: 70
Study 12670841 — intervention group
Group type: EXPERIMENTAL
Intervention: On-deflate method with air in the stomach
Number of subjects: 70
Study 12670841 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall findings
Number of subjects: 70
Study 16380697 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemodialysis patients
Number of subjects: 30
Study 16380697 — intervention group
Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 30
Study 16380697 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemodialysis
Number of subjects: 30
Study 10332180 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive strategies including reduced route march speed (from 7.5 to 5 km/h), running on softer surfaces, promoting individual step length, wider spacing in formations, and interval-running training.
Number of subjects: 161
Study 7551848 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid therapy
Number of subjects: 50
Study 7551848 — intervention group
Group type: COMPARATOR
Intervention: Control group (age-matched controls)
Number of subjects: 50
Study 7551848 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall treatment outcomes
Number of subjects: 50
Study 7551848 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone therapy
Number of subjects: 50
Study 1936511 — intervention group
Group type: EXPERIMENTAL
Intervention: Voltaren Emulgel
Number of subjects: 120
Study 1936511 — intervention group
Group type: COMPARATOR
Intervention: Regular gel
Number of subjects: 120
Study 6182412 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine 5 mg, 10 mg, 20 mg (each given three times daily for 1 week)
Number of subjects: 6
Study 6182412 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine (higher doses)
Number of subjects: 6
Study 6182412 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine (all doses)
Number of subjects: 6
Study 28248854 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency chest wall oscillation (HFCWO)
Number of subjects: 73
Study 28248854 — intervention group
Group type: COMPARATOR
Intervention: Conventional chest physical therapy (CCPT)
Number of subjects: 73
Study 25474232 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin glue-assisted conjunctival autograft (CAG)
Number of subjects: 47
Study 25474232 — intervention group
Group type: COMPARATOR
Intervention: Fibrin glue-assisted conjunctivolimbal autograft (CLAG)
Number of subjects: 47
Study 24419418 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance pemetrexed (500 mg/m)
Number of subjects: 539
Study 24419418 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 539
Study 22525900 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene citrate alone
Number of subjects: 626
Study 22525900 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin alone
Number of subjects: 626
Study 22525900 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene citrate plus metformin
Number of subjects: 626
Study 22525900 — intervention group
Group type: COMPARATOR
Intervention: Anovulatory cycles with progestin withdrawal
Number of subjects: 626
Study 22525900 — intervention group
Group type: COMPARATOR
Intervention: Anovulatory cycles without progestin withdrawal
Number of subjects: 626
Study 22525900 — intervention group
Group type: COMPARATOR
Intervention: Spontaneous menses
Number of subjects: 626
Study 19204305 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT‐P
Number of subjects: 1520
Study 19204305 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT‐D
Number of subjects: 1520
Study 19204305 — intervention group
Group type: COMPARATOR
Intervention: Optimal pharmacological therapy
Number of subjects: 1520
Study 17333304 — intervention group
Group type: EXPERIMENTAL
Intervention: Visalys whitening (VW)
Number of subjects: 60
Study 17333304 — intervention group
Group type: EXPERIMENTAL
Intervention: Opalescence PF (OP)
Number of subjects: 60
Study 17333304 — intervention group
Group type: COMPARATOR
Intervention: Both groups (VW and OP)
Number of subjects: 60
Study 15304029 — intervention group
Group type: COMPARATOR
Intervention: Combination chemotherapy (CT) alone
Number of subjects: 84
Study 15304029 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination chemotherapy (CT) plus low-molecular-weight heparin (LMWH)
Number of subjects: 84
Study 11236499 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunotherapy (oral hyposensitization with mite allergens) in combination with ointment containing retinopalmitate and methyluracil
Number of subjects: 99
Study 11236499 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment combined with the administration of placebo
Number of subjects: 99
Study 11236499 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy only
Number of subjects: 99
Study 10082447 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandimmun (SAN)
Number of subjects: 10
Study 10082447 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoral (NEO)
Number of subjects: 10
Study 10082447 — intervention group
Group type: COMPARATOR
Intervention: Trough levels
Number of subjects: 10
Study 8042821 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorambucil (0.15 mg/kg body weight per day orally) and prednisone (three intravenous pulses of 1 g of methylprednisolone followed by oral prednisone at 0.5 mg/kg per day)
Number of subjects: 18
Study 8042821 — intervention group
Group type: COMPARATOR
Intervention: Intravenous cyclophosphamide (750 mg/m2 body surface area once every month for 6 months) and methylprednisolone (three intravenous 1-g pulses)
Number of subjects: 18
Study 2892771 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (doses reducing resting heart rate by 25%)
Number of subjects: 174
Study 2892771 — intervention group
Group type: COMPARATOR
Intervention: Placebo (oral vitamin K)
Number of subjects: 174
Study 2892771 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 174
Study 30374832 — intervention group
Group type: EXPERIMENTAL
Intervention: Xenogenic graft plus modified perforated membranes (MPM)
Number of subjects: 15
Study 30374832 — intervention group
Group type: COMPARATOR
Intervention: Xenogenic graft plus standard collagen membranes (CM)
Number of subjects: 15
Study 28694338 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercial web‐based cognitive training program
Number of subjects: 128
Study 28694338 — intervention group
Group type: COMPARATOR
Intervention: Web‐based video games (control)
Number of subjects: 128
Study 25482957 — intervention group
Group type: EXPERIMENTAL
Intervention: WBV (whole-body vibration) plus balance exercise
Number of subjects: 20
Study 25482957 — intervention group
Group type: COMPARATOR
Intervention: STE (standard balance exercise)
Number of subjects: 20
Study 23337369 — intervention group
Group type: EXPERIMENTAL
Intervention: Pictograph‐guided adherence counseling
Number of subjects: 446
Study 23337369 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard adherence counseling
Number of subjects: 446
Study 23337369 — intervention group
Group type: COMPARATOR
Intervention: General health improvement counseling
Number of subjects: 446
Study 21342008 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioabsorbable collagen barrier
Number of subjects: 11
Study 21342008 — intervention group
Group type: COMPARATOR
Intervention: Non-resorbable expanded polytetrafluoroethylene (ePTFE) barrier
Number of subjects: 11
Study 19774436 — intervention group
Group type: EXPERIMENTAL
Intervention: 8.8 g/day of plant stanols
Number of subjects: 49
Study 19774436 — intervention group
Group type: COMPARATOR
Intervention: Control group (no plant stanol esters)
Number of subjects: 49
Study 17174637 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 9467
Study 17174637 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 9467
Study 15955130 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10 mg
Number of subjects: 3140
Study 15955130 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin 10 mg
Number of subjects: 3140
Study 15955130 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin 20 mg
Number of subjects: 3140
Study 15955130 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin 20 mg
Number of subjects: 3140
Study 15955130 — intervention group
Group type: COMPARATOR
Intervention: Pravastatin 40 mg
Number of subjects: 3140
Study 11991783 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity exercise (76.0 +/- 6.0% of VO2peak)
Number of subjects: 10
Study 11991783 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity exercise (44.5 +/- 5.5% of VO2peak)
Number of subjects: 10
Study 11991783 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise (62.3 +/- 3.8% of VO2peak)
Number of subjects: 10
Study 11991783 — intervention group
Group type: COMPARATOR
Intervention: Resting control session
Number of subjects: 10
Study 10803268 — intervention group
Group type: EXPERIMENTAL
Intervention: Nucleic acid hybridization for HPV DNA detection (group C)
Number of subjects: 236
Study 10803268 — intervention group
Group type: COMPARATOR
Intervention: Nucleic acid hybridization for HPV DNA detection (group A and B)
Number of subjects: 236
Study 10803268 — intervention group
Group type: EXPERIMENTAL
Intervention: Nucleic acid hybridization with pap smear results
Number of subjects: 236
Study 10803268 — intervention group
Group type: EXPERIMENTAL
Intervention: Age group analysis
Number of subjects: 236
Study 7786910 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term migrants
Number of subjects: 198
Study 7786910 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term migrants
Number of subjects: 198
Study 7786910 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall psychiatric morbidity
Number of subjects: 198